# Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)

> **NCT00962923** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 20 (estimated)

## Conditions studied

- Systemic Sclerosis
- Mesenchymal Stem Cells

## Interventions

- **BIOLOGICAL:** Allogeneic Mesenchymal Stem Cells (AlloMSC)

## Key facts

- **NCT ID:** NCT00962923
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-08
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962923, "Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00962923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*